NACC EXECUTIVE TEAM

NACC EXECUTIVE TEAM

NACC
EXECUTIVE TEAM


The Executive team of the NACC is composed of the Chairs of the respective NACC Subcommittees.

 

NACC & ITS MEMBERS

sample70

Yolanda

Simon

sample70

Ms. Heather

Rodney

sample70

Ms Jacqueline

Reid

sample70

Mr. Steve

Baras

sample70

Ms. Cyrus

Williams

sample70

Mr. Eswick

Padmore

sample70

Ms. Delores

Robinson

sample70

Ms. Dianna

Weekes

sample70

Ms. Kimberly

Gilbert

How It Began

How It Began

OUR
HISTORY


The principles that guide the Trinidad and Tobago National HIV and AIDS Policy are aligned with those upon which Vision 2030 and the NSP are premised.

  • Political leadership and commitment: Strong political leadership and commitment at all levels are critical to an effective, comprehensive and sustained national response.

  • Good governance, transparency and accountability: Human, financial and organisational resources will be mobilized and managed in an effective, transparent and accountable manner. The policy would be widely disseminated and progress assessed against benchmarks and targets on an annual basis.

  • Equity: All persons can access information, prevention, treatment, care and support services regardless of HIV or other health status, sexual orientation, gender identity, age, disability, religious beliefs, socio-economic status, immigration status, incarceration status, geographic location, level of literacy or vulnerability to exposure.

  • Gender equality. With HIV and AIDS being a social, cultural and economic phenomenon gender equality is imperative in addressing sexual and reproductive health. Women and girls are particularly vulnerable to HIV infection. Men and boys are also vulnerable and their needs should also be included in all programming and prevention interventions.

  • Promotion and protection of human rights: All persons infected, perceived as infected or affected by HIV have the right to equality before the law and freedom from discrimination, and to be treated with dignity and respect in all areas of daily life. The National HIV and AIDS Policy draws attention to the compelling public health rationale to overcome stigmatization and discrimination in society, including the impact of gender norms and stereotypes. Reducing stigma and discrimination towards people living with HIV and key populations is critical for an effective national response.

  • Collaboration: A comprehensive national response utilizes the full range of effective, evidence-based policy and programmatic interventions, and involves all stakeholders in decision-making, planning, implementing and monitoring.

  • Inclusion: Meaningful participation by all groups in society in decision-making, planning, implementing, monitoring and evaluating the national response to HIV is critical for an effective and sustainable response. It is also critical to understand and meet the needs of PLHIVs, KPs, vulnerable groups and others who face high levels of stigma and discrimination and as a result, may be deterred from accessing health and other services.

  • Community systems strengthening and participation: Community actors working together with the formal health sector are critical to the long-term sustainability of effective interventions for epidemic control. Programmes designed, led, implemented and supported by the community should be evidence-informed, cost-effective, sustainable, and include support for KPs and vulnerable groups unable or unwilling to access government-provided services. Community networks, linkages and partnerships should be supported and integrated into the national programme.

  • Evidence based programming: All programmes and interventions are to be designed taking into account the factors driving the epidemic within locations and subpopulations and should be based on the epidemiological, economic, social, and demographic contexts of the country.

  • Regulatory role of the Ministry of Health: The regulatory framework for the provision of health services provides up-to-date and scientifically sound guidelines for the delivery of HIV and related services.

  • Efficiency: Strategies, resources and inputs for the HIV response are integrated with other national development and health efforts to enhance overall efficiency and potential for sustainability. This includes the equitable and sustainable resourcing of the health sector in alignment with national priorities, policies and strategies.

  • Sustainability: in light of the changing economic environment, donor landscape and limited available resources emphasis would be placed on value for money, funds must be spent for the greatest impact and in the most efficient way, foster increased and continued country ownership, efficiency and sustainable financing

HIV and COVID-19

HIV and COVID-19

HIV &
COVID-19


COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. This virus was discovered in China in 2019 and has continued to spread around the world, resulting in a global pandemic. There is currently no cure for COVID-19.

COVID-19 is transmitted when people breathe in droplets that have been exhaled by an infected person. In some cases, people may contract COVID-19 if they come into contact with contaminated body fluids that reach the eyes, nose or mouth.

Symptoms can range from mild to severe. In severe cases it causes respiratory symptoms, including difficulty breathing. COVID-19 can also affect other parts of the body, including causing body aches and joint pain, or causing gastrointestinal symptoms such as diarrhea and nausea.

In 2021, vaccines became available that prevent severe disease outcomes. In some countries, antiviral treatment can also help lessen the severity of the disease.

THE FACTS ABOUT COVID-19, HIV & YOU

COVID-19 And PLHIV

We are still learning about COVID-19 and how it affects people living with HIV, but we know that it is important for PLHIV to continue taking antiretroviral medications to keep the immune system healthy.

Talk with your care team to be sure you have an adequate supply of ART on hand.

For PLHIV who are virally suppressed, it is thought that COVID-19 affects this group about the same as the general population – that is, virally suppressed PLHIV are likely not at greater risk of contracting or experiencing severe COVID-19 illness.

For PLHIV who are unsuppressed, it is important to work with your care team to achieve viral suppression through good adherence and proper medications.

COVID-19 Signs and Symptoms

COVID-19 has several symptoms and signs. Many of these are very common and are associated with other illnesses.

Common symptoms include fever, tiredness, and a dry cough. Some people may also experience shortness of breath, a temporary loss of smell or loss of taste, or diarrhea. These symptoms usually resolve in approximately 10 days.

In severe cases persons may experience high fevers, pneumonia, and difficulty breathing.

It takes anytime between 1 and 12 days for symptoms to appear after exposure to the virus.

Many persons may never present with any of these signs or symptoms, known as asymptomatic cases.

a1

COVID-19 Testing

If you are experiencing symptoms of COVID-19 (coughing, fever, shortness of breath, diarrhoea, loss of taste or smell), it is a good idea to get a COVID-19 test. For up-to-date information on where to access testing, review the Ministry of Health page on COVID-19 testing and screening.

COVID-19 Prevention

Practice basic COVID precautions:

  • Wear well-fitting masks, wash hands, maintain distance of 1 meter from people who are not in your household

  • Stay at home when you feel unwell, and if you have a fever or other COVID-19 symptoms

  • Cover mouth and nose when coughing

  • Cough into elbow

  • Wash hands frequently

  • Do not touch eyes, nose, or mouth

  • Get vaccinated and boosted to reduce your chance of serious illness or death

Notify your health provider if experiencing symptoms. Follow their guidance about seeking care and quarantining.

For more information, visit the Ministry of Health COVID-19 information page on COVID-19 prevention.

COVID-19 Vaccination

You may be concerned about COVID-19, vaccinations, and HIV. In general, PLHIV who are virally suppressed typically respond well to vaccines.

COVID-19 vaccines bring the same benefits to PLHIV as they bring to all individuals and communities, including prevention of severe disease and the potential for reduced transmission of COVID-19.

The Ministry of Health offers additional information about COVID-19 vaccination, including information on where and how to get vaccinated.

If you have any other questions or concerns, reach out to your medical provider.

U and Your Baby - HIV and Pregnancy

U and Your Baby - HIV and Pregnancy

U & YOUR BABY
HIV & PREGNANCY


Just as you can have a full life as a PLHIV, you can also give life. In this section, we examine all you need to know about HIV and pregnancy.

You may be wondering if you can have HIV and still have a baby. You most certainly can! You can enjoy the full benefits of parenthood as PLHIV. Let’s consider some questions that you may have.

THE FACTS ABOUT HIV, PREGNANCY & YOUR BABY

Can You Breastfeed If You Have HIV?

The current recommendation is that people living with HIV should NOT breastfeed or pre-chew food for their babies. Keeping an undetectable viral load greatly lowers, but does not remove, the risk of transmitting HIV through breastfeeding. If you have questions about breastfeeding or desire to breastfeed, talk to your doctor about infant feeding options. Mothers can certainly still preserve healthy bonds with their babies using other feeding methods.

What Is The Safest Way To Conceive?

Yes. A person living with HIV can transmit HIV to their baby any time during pregnancy, childbirth, or breastfeeding. Remember though that this doesn’t mean that you can’t have children. You just have to work closely with your Dream Team.

Following the guidelines regarding ART can prevent transmission of HIV to your baby and protect your health.

Are HIV Medicines Safe For You To Use During Pregnancy?

Yes - most HIV medicines are safe to use during pregnancy. While your pregnancy journey may feel private, talk with your doctor at your Treatment Site about the benefits and risks of specific HIV medicines during pregnancy or while you are trying to get pregnant.

Your Dream Team will be able to guide you well.

What Should You Ask Your Treatment Team About Having A Baby

You might ask your health care provider some of these questions:

  • What is the safest way to conceive?

  • Will HIV cause problems for me during pregnancy or delivery?

  • Will my HIV treatment cause problems for my baby?

  • What are the pros and cons of taking HIV medicine while I am pregnant?

  • Is my viral load undetectable?

  • How do I avoid transmitting HIV to my partner(s), surrogate, or baby during conception, pregnancy, and delivery?

What Are Other Ways That I Can Have A Baby?

Adopting a baby is also an option for people with HIV who want to begin, or expand their families. You can certainly enjoy parenthood with adoption as this means that you would have full legal responsibility for that child. You would also be giving a child a home.

If you would like to learn more, feel free to reach out to the Children’s Authority of Trinidad and Tobago.

Can A Couple Conceive A Baby Without The Uninfected Partner Becoming Infected?


Many couples in which one person is HIV positive and the other person isn't want to have children. With careful planning, it is possible to have a safe and successful pregnancy while preventing HIV from passing to the HIV-negative partner (or to the baby). It is very important to discuss your desires and intentions for childbearing with your health care provider before the woman decides to become pregnant. Your provider can help with decisions about how to conceive safely (if your provider is not familiar with reproductive issues for HIV, ask to see an HIV specialist).

Are There Any More Options For Fathering/Having A Child?

If you are a man living with HIV, the question above may be one that you have considered. While the typical means of conceiving may be some couples’ ‘go-to’ method, there are still other ways in which a person can begin or expand their/her/his family.

Although not currently available in Trinidad and Tobago, a discordant couple can access PrEP, in order to protect the HIV negative partner from getting the virus during sexual intercourse and conception. The negative person should start PrEP at their doctor’s recommendation and approval before the couple tries to have a child.

Another option for conception is through in vitro fertilization (IVF) and intrauterine insemination (IUI). Fortunately, in Trinidad and Tobago, we have two Fertility Treatment Centers that offer these services. They are the Trinidad and Tobago IVF and Fertility Centre and the Barbados Fertility Clinic

For other questions on HIV and pregnancy,
call the National HIV Helpline 800-4HIV or 800-4448. (This is a toll-free number)

You are not alone. #youarenotalonett.


PREVIOUS TOPIC: 
Comfort Care


NEXT TOPIC: 
HIV and COVID-19

Events

Event

UPCOMING
EVENTS


PUBLIC CONSULTATIONS ON THE NATIONAL POLICY ON HIV AND AIDS


Dear Stakeholders, The NACC wises to invite you to our upcoming consultations on the National Policy on HIV and AIDS. In persons consultations will be held on August 29th 2023 , September 7th and September 14th. Please indicate your preference for attendance by completing the registration link below.

Event Registrations for Public Consultations on The National Policy on HIV & AIDS
 

PAST & UPCOMING CALENDAR OF EVENTS & More

Green Paper


image_hover

Green Paper Feedback Form


image_hover

Policy Mind Map


image_hover

Media

Media

MEDIA
RELEASES


World AIDS Day 2022 -
December 1st

Unite to end the inequalities holding back the end of AIDS.

Image 1 - scenic view
Image 2 - landscape
Image 3 - city view
Image 3 - city view


Since 1988, the world has celebrated World AIDS Day in remembrance of all those who have died of AIDS-related illnesses and those living positively and bravely with HIV. World AIDS Day remains as relevant today as it’s always been, reminding people and governments that HIV has not gone away. There is still a critical need for increased funding for the AIDS response, to increase awareness of the impact of HIV on people’s lives, to end stigma and discrimination and to improve the quality of life of people living with HIV. The human cost of inaction on AIDS is an injustice by governments and people alike, if action is not taken to end AIDS.

PREVIOUS & CURRENT  MEDIA RELEASES & More